Fibrocor Therapeutics Inc. Announces Appointment of Industry Veteran William C. Fanslow Ph.D., as Senior Vice President Drug Development
TORONTO, CANADA / ACCESSWIRE / OCTOBER 27, 2020 – Fibrocor Therapeutics Inc. (“Fibrocor” or “the Company”), a privately held developer of de novo therapeutics to treat Fibrosis, announced today the appointment of industry veteran William […]